Clinical Trial Update: Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mycophenolate mofetil to cyclophosphamide for active Takayasu arteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Takayasu Arteritis | Phase 3 | Status: COMPLETED